An Duy Tran

Development and Use of Prediction Models for Classification of Cardiovascular Risk of Remote Indigenous Australians

A Tran-Duy, Robyn McDermott, Josh Knight, Xinyang Hua, Elizabeth LM Barr, Kerry Arabena, Andrew Palmer, Philip Clarke

Journal article  |  2020  |  Heart, Lung and Circulation

Background: Cardiovascular disease (CVD) is the leading cause of death for Indigenous Australians. There is widespread belief that..

The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood

Seamus Kent, Frauke Becker, Talitha Feenstra, Tran-Duy An, Iryna Schlackow, Michelle Tew, Ping Zhang, Wen Ye, Lizheng Shi, William Herman, Phil McEwan, Wendelin Schramm, Alastair Gray, Jose Leal, Mark Lamotte, Michael Willis, Andrew J Palmer, Philip Clarke

Journal article  |  2019  |  PharmacoEconomics

Transparency in health economic decision modelling is important for engendering confidence in the models and in the reliability of..

Multicentre randomised double-blind placebo controlled trial of combination vancomycin and cefazolin surgical antibiotic prophylaxis: the Australian surgical antibiotic prophylaxis (ASAP) trial

Trisha Peel, Sarah Astbury, Allen C Cheng, David Paterson, Kirsty Buising, Tim Spelman, Tran-Duy An, Richard S de Steiger, Peter Choong, Allen Cheng, David Paterson, Kirsty Buising, Michelle Dowsey, Ross Crawford, Tim Spelman, Philip Clarke, Ben Howden, Peter Rehfisch, Robert Molnar, Sam Adie, et al.

Journal article  |  2019  |  BMJ Open

INTRODUCTION: Resistant Gram-positive organisms, such as methicillin-resistant staphylococci, account for a significant proportion..

Chewing gum to treat postoperative nausea and emesis in female patients (CHEWY): rationale and design for a multicentre randomised trial

Jai Darvall, Britta Sylvia von Ungern-Sternberg, Sabine Braat, David Story, Andrew Davidson, Megan Allen, Tran-Duy An, Dana Middleton, Kate Leslie

Journal article  |  2019  |  BMJ Open

MODELLING PROGRESSION OF RISK FACTORS IN PATIENTS WITH TYPE 1 DIABETES: TOWARDS THE MOST APPROPRIATE FUNCTIONAL FORMS FOR A SIMULATION MODEL OF LONG-TERM HEALTH OUTCOMES

A Tran-Duy, J Knight, AJ Palmer, B Eliasson, AM Svensson, PM Clarke

Conference Proceedings  |  2019  |  Value in Health

IMPACT OF COMORBID CONDITIONS ON HEALTH CARE EXPENDITURE AND WORK-RELATED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS: A RETROSPECTIVE ANALYSIS USING THE MEDICAL EXPENDITURE PANEL SURVEY IN THE PERIOD 2006-2015

MV Vu, N Carvalho, R Buchbinder, G McColl, PM Clarke, A Tran-Duy

Conference Proceedings  |  2019  |  Value in Health

Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study

A Tran-Duy, NJ Connell, FH Vanmolkot, PC Souverein, NJ de Wit, CDA Stehouwer, AW Hoes, F de Vries, A de Boer

Journal article  |  2019  |  Journal of Internal Medicine

An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial

An Tran-Duy, Marjan Ghiti Moghadam, Martijn AH Oude Voshaar, Harald E Vonkeman, Annelies Boonen, Philip Clarke, Geoff McColl, Peter M ten Klooster, TR Zijlstra, Willem F Lems, N Riyazi, EN Griep, JMW Hazes, Robert Landewe, Hein J Bernelot Moens, Piet LCM van Riel, Mart AFJ van de Laar, TL Jansen

Journal article  |  2018  |  Arthritis and Rheumatology

Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge

Andrew J Palmer, Lei Si, Michelle Tew, Xinyang Hua, Michael S Willis, Christian Asseburg, Phil McEwan, Jose Leal, Alastair Gray, Volker Foos, Mark Lamotte, Talitha Feenstra, Patrick J O'Connor, Michael Brandle, Harry J Smolen, James C Gahn, William J Valentine, Richard F Pollock, Penny Breeze, Alan Brennan, et al.

Journal article  |  2018  |  Value in Health

Longevity of outstanding sporting achievers: Mind versus muscle

An Tran-Duy, David C Smerdon, Philip M Clarke

Journal article  |  2018  |  PLOS ONE

Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort

Xinyang Hua, Robyn McDermott, Thomas Lung, Mark Wenitong, An Tran-Duy, Ming Li, Philip Clarke

Journal article  |  2017  |  European Journal of Preventive Cardiology

Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis Reply

An Tran-Duy, Bart Spaetgens, Arno W Hoes, Niek J De Wit, Coen DA Stehouwer

Journal article  |  2017  |  Clinical Gastroenterology and Hepatology

Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis

An Tran-Duy, Bart Spaetgens, Arno W Hoes, Niek J de Wit, Coen DA Stehouwer

Journal article  |  2016  |  Clinical Gastroenterology and Hepatology

Construct validity of radiographs of the feet to assess joint damage in patients with gout

B Spaetgens, C van Durme, C Webers, A Tran-Duy, T Schoonbrood, A Boonen

Journal article  |  2016  |  The Journal of Rheumatology

Increased Eligibility for Attempting Treatment-Free Remission (TFR) with Frontline Nilotinib (NIL) vs Imatinib (IM) in Patients with Philadelphia Chromosome-Positive (Ph plus ) Chronic Myeloid Leukemia (CML): Results of a Stochastic Simulation Model

Francois-Xavier Mahon, An Tran-Duy, Raechelle G Ocampo, David Ray, Estella Mendelson, Aby Buchbinder, Pascal Edrich, Sonya J Snedecor, Giuseppe Saglio

Conference Proceedings  |  2015  |  BLOOD

Longitudinal Analyses of Presenteeism and Its Role as a Predictor of Sick Leave in Patients With Ankylosing Spondylitis

An Tran-Duy, Thien TV Nguyen, Herbert Thijs, Xenofon Baraliakos, Frank Heldmann, Juergen Braun, Annelies Boonen

Journal article  |  2015  |  Arthritis Care & Research

IMPLEMENTATION OF POPULATION DYNAMICS IN MODELLING HEALTH AND BUDGET IMPACT OF AN INTERVENTION FOR A CHRONIC DISEASE WITH MULTIPLE DISEASE SUBTYPES

A Tran-Duy, A Boonen, JJ Carol, JL Severens

Journal article  |  2015  |  Value in Health

CO-ADMINISTRATION OF PROTON PUMP INHIBITORS IN CHRONIC ASPIRIN USERS AND THE RISK OF ADVERSE CARDIOVASCULAR EVENTS: A POPULATION-BASED COHORT STUDY

A Tran-Duy, FH Vanmolkot, PC Souverein, AW Hoes, A de Boer, CD Stehower, NJ de Wit, MA Joore, F de Vries

Journal article  |  2015  |  Value in Health

Impact on total population health and societal cost, and the implication on the actual cost-effectiveness of including tumour necrosis factor-alpha antagonists in management of ankylosing spondylitis: a dynamic population modelling study

An Tran-Duy, Annelies Boonen, Mart AFJ van de Laar, Johan L Severens

Journal article  |  2015  |  Cost Effectiveness and Resource Allocation

Should patients prescribed long-term low-dose aspirin receive proton pump inhibitors? A systematic review and meta-analysis

A Tran-Duy, FH Vanmolkot, MA Joore, AW Hoes, CDA Stehouwer

Journal article  |  2015  |  International Journal of Clinical Practice

Health and Utilities in Patients With Gout Under the Care of a Rheumatologist

B Spaetgens, A Tran-Duy, JMA Wijnands, S van der Linden, A Boonen

Journal article  |  2015  |  Arthritis Care & Research

Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment

Ron LH Handels, Manuela A Joore, An Tran-Duy, Anders Wimo, Claire AG Wolfs, Frans RJ Verhey, Johan L Severens

Journal article  |  2015  |  Alzheimer's & Dementia

Modelling Outcomes of Complex Treatment Strategies Following a Clinical Guideline for Treatment Decisions in Patients with Rheumatoid Arthritis

An Tran-Duy, Annelies Boonen, Wietske Kievit, Piet LCM van Riel, Mart AFJ van de Laar, Johan L Severens

Journal article  |  2014  |  PharmacoEconomics

How to Select the Right Cost-Effectiveness Model?

HGM van Haalen, JL Severens, A Tran-Duy, A Boonen

Journal article  |  2014  |  PharmacoEconomics

HOW TO SELECT THE RIGHT COST-EFFECTIVENESS MODEL? A SYSTEMATIC REVIEW AND STEPWISE APPROACH FOR TRANSFERRING AN EXISTING HEALTH ECONOMIC MODEL FOR RHEUMATOID ARTHRITIS

HGM van Haalen, A Tran-Duy, A Boonen, JL Severens

Conference Proceedings  |  2013  |  Value in Health

Presenteeism Predicts Sick Leave Better Than Basdai and/Or BASFI In A Longitudinal Cohort Of Patients With Ankylosing Spondylitis (EASIC)

Thi Vinh Nguyen Thien, An Tran-Duy, Frank Heldmann, Juergen Braun, Herbert Thijs, Annelies Boonen

Conference Proceedings  |  2013  |  ARTHRITIS AND RHEUMATISM

Comparison Of The Cost-Effectiveness Of The Treatment Strategies With and Without Biological Response Modifiers For Patients With Recently Diagnosed Rheumatoid Arthritis Following A Clinical Guideline For Treatment Selection

An Tran-Duy, Annelies Boonen, Wietske Kievit, Piet LCM van Riel, Mart AFJ van de laar, Johan L Severens

Conference Proceedings  |  2013  |  ARTHRITIS AND RHEUMATISM

SIMULTANEOUSLY MODELLING HEALTH IMPACT, BUDGET IMPACT AND COST-EFFECTIVENESS IN THE CONTEXT OF POPULATION DYNAMICS: THE CASE OF TUMOUR NECROSIS FACTOR-ALPHA ANTAGONIST FOR ANKYLOSING SPONDYLITIS IN THE DUTCH SOCIETY

A Tran-Duy, A Boonen, MAFJ van de Laar, JL Severens

Conference Proceedings  |  2012  |  CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

A discrete event modelling framework for simulation of long-term outcomes of sequential treatment strategies for ankylosing spondylitis

An Tran-Duy, Annelies Boonen, Mart AFJ van de Laar, Angelinus C Franke, Johan L Severens

Journal article  |  2011  |  Annals of the Rheumatic Diseases

COST-EFFECTIVENESS OF TREATMENT STRATEGIES FOR ANKYLOSING SPONDYLITIS: FIRST RESULTS OF A DISCRETE EVENT SIMULATION MODEL

Duy A Tran, A Boonen, J Arsenijevic, JL Severens

Conference Proceedings  |  2010  |  Value in Health